Phlow Corp., a Public Benefit Corporation, today announced that it has joined a select group of purpose-driven businesses by becoming the first pharmaceutical manufacturer based in America to earn B Corporation™ (B Corp™) certification. The new certification further...
Press Releases
Phlow Announces the Appointment of Kerry Ingalls and Guy Villax to its Board of Directors
Phlow Corp., a Public Benefit pharmaceutical manufacturer, announced today the appointment of Kerry Ingalls and Guy Villax to its Board of Directors amid a period of rapid growth and operational scale-up of facilities for Phlow. Ingalls and Villax will join Phlow's...
Phlow Announces over $35M in Series B Funding to Improve the U.S. Medicine Supply Chain
Phlow Corp., a U.S.-based public benefit corporation and contract development and manufacturing organization (CDMO), today announced that it has closed a $36 million Series B capital raise as part of its mission to protect America’s medicine cabinet. Since its launch...
Phlow Corp. Announces Formation of Business Advisory Board, New Board of Directors Appointment and Corporate President as Company Accelerates Towards Next Stage of Growth
Addition of internationally recognized advisors, new board member, and President highlight Phlow’s commitment to create a reliable supply of affordable, high-quality essential medicines and deliver advanced manufacturing expertise to the pharmaceutical industry....
Phlow Corp. and U.S. Pharmacopeia Announce the Opening of Laboratories at the Advanced Pharmaceutical Development Center in Richmond, Virginia
Phlow Corp. and U.S. Pharmacopeia Announce the Opening of Laboratories at the Advanced Pharmaceutical Development Center in Richmond, Virginia Richmond, VA., December 12, 2022 – Today, Phlow Corp., a U.S.-based public benefit corporation and contract development and...
Phlow Joins End Drug Shortages Alliance
Richmond, VA, June 29, 2022 – Phlow™ Corp. announced today it has joined a new coalition of diverse stakeholders to address drug shortages in the United States. The End Drug Shortages Alliance provides a forum for key stakeholders to take strategic aim at one of...
Phlow™ to Provide Innovative Continuous Manufacturing Research & Development Services for Small Molecule Pharmaceutical Product Development in the Commercial Sector
Phlow Enters into Agreements with Virginia Commonwealth University’s Medicines for All Institute, AMPAC Fine Chemicals and Dr. Malcolm Berry, PhD, joins Phlow Team to Provide Industry-Leading Expertise RICHMOND, Va. (March 21, 2022)- Phlow Corp., a U.S.-based...
Phlow Launches Key Essential Medicines to Leading Children’s Hospitals to Help Alleviate Impact of Shortages
Children’s Hospital Coalition (CHC) encourages more children’s hospitals to join and tackle the shortage crisis RICHMOND, Va., March 9, 2022 -- Phlow, a U.S.-based, public benefit impact-driven pharmaceutical company, announced the launch of key essential medicines,...
Phlow Included in BARDA Contract Development and Manufacturing Organization Network to Provide Domestic API Capability for Essential Medicines and Medical Countermeasures
Phlow Corp announces that it has been approved for inclusion in the Biomedical Advanced Research and Development Authority (BARDA) contract development and manufacturing organization (CDMO) network.
Fresenius Kabi USA and Phlow Corp. Announce Alliance to Enhance the Supply of Essential Medicines for U.S. Patients
Fresenius Kabi USA and Phlow Corp. announce an alliance to reliably supply high-quality essential medicines utilizing advanced manufacturing processes based in the USA.